Ardelyx ARDX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| IBSRELA | $70.07M+57.8% | $86.6M+60.8% | $78.16M+92.3% | $65.05M+83.5% | $44.4M+56.6% | |
| Licensing revenue | $51K-99.0% | $23K+4.5% | $25K+25.0% | $20K+5.3% | $5.02M+29,429% | |
| Non-cash royalty revenue related to the sale of future royalties | $695K-32.3% | $1.35M+47.4% | $500M+61,705% | $1.38M+130% | $1.03M+179% | |
| Product supply revenue | $354K+39.4% | $9.44M+125% | $0-100% | $6.19M+47,477% | $254K-88.1% | |
| XPHOZAH | $23.3M-0.5% | $27.8M-51.4% | $27.36M-46.8% | $25.03M-32.6% | $23.41M+54.5% | |
| Cost of Sales by Product | ||||||
| Other cost of revenue | $1.94M-80.6% | $7.91M-49.1% | $1.32M-90.6% | $9.16M+14.0% | $9.96M+62.9% | |
| Product sales, net | $2.88M+22.9% | $2.94M+8.1% | $2.66M+55.2% | $3.25M+131% | $2.34M+131% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ardelyx break its business down?
- Ardelyx (ARDX) reports total revenues by product across 5 parts — IBSRELA, Licensing revenue, Non-cash royalty revenue related to the sale of future royalties, Product supply revenue and XPHOZAH. Each is extracted from the segment footnotes and tracked over time.
- Where does Ardelyx's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ardelyx's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
